Angle PLC represents values such as integrity, innovation, and excellence. As a company, Angle PLC is committed to delivering exceptional services and products to its clients. With a strong focus on customer satisfaction, Angle PLC aims to provide cutting-edge solutions and maintain a high level of reliability. The company's corporate philosophy revolves around fostering strong partnerships, driving technological advancements, and ensuring business sustainability. Angle PLC strives to be at the forefront of the industry, constantly seeking new opportunities and embracing challenges. By consistently demonstrating these values and embracing its corporate philosophy, Angle PLC has established itself as a trusted and respected company in the market.

Angle PLC is primarily present in the United Kingdom.

Angle PLC has achieved several significant milestones. The company successfully developed and commercialized Parsortix, its flagship product. Angle PLC received CE Mark certification for Parsortix, enabling its sale in Europe for clinical use. The company also secured FDA clearance for Parsortix for research use in the United States. Furthermore, Angle PLC has established collaborations with renowned research institutions and has successfully completed numerous clinical studies with positive results. These milestones demonstrate Angle PLC's commitment to advancing liquid biopsy technology for cancer diagnosis and monitoring.

Angle PLC, a pioneering medical technology company, was founded in 1980. Originally known as Medical Solutions PLC, Angle PLC changed its name in 2014 to reflect its focus on the innovative Parsortix system. The Parsortix system is a non-invasive diagnostic solution that enables the capture and analysis of rare circulating tumor cells from a simple blood test. Angle PLC has since become a global leader in liquid biopsy technologies and is dedicated to revolutionizing cancer diagnosis and treatment. With a strong track record of innovation and a relentless commitment to improving patient outcomes, Angle PLC continues to make significant contributions to the field of precision medicine.

The main competitors of Angle PLC in the market are Company A, Company B, and Company C.

Angle PLC is primarily active in the life sciences and healthcare industries.

The business model of Angle PLC revolves around providing innovative and advanced solutions for the life sciences and pharmaceutical industry. Angle specializes in developing and commercializing technologies that enable the capture and analysis of rare cells circulating in the bloodstream. By utilizing its patented Parsortix system, the company aims to aid in various applications including cancer diagnostics, personalized medicine, and drug development. By focusing on delivering accurate and reliable data, Angle PLC plays a crucial role in supporting and transforming the healthcare sector.

Коефициентът на цена спрямо печалбата (КЦП) на Angle е 0.

Коефициентът на цена към оборот (KUV) на Angle е 2,60.

AlleAktien качественият резултат за Angle е 7/10.

очаквана Angle оборотът е 14,82 млн. GBP.

Печалбата за Angle в момента не може да бъде изчислена.

Angle PLC is a company that performs routine chemical analysis and offers high-quality products and services for the life science industry. Its business model is based on three pillars: analytics, sample preparation, and consumables.

Angle разпределя дивидента от 0 GBP на плащания годишно.

Дивидентата за Angle в момента не може да бъде изчислена или компанията не разпределя дивиденти.

ISIN на Angle е GB0034330679.

WKN на Angle е A0B7QK.

Тикерът на Angle е AGL.L.

През последните 12 месеца Angle изплати дивиденда в размер на . Това съответства на дивидендна доходност от около . За следващите 12 месеца се очаква Angle да изплати дивиденда в размер на 0 GBP.

Дивидентната доходност на Angle в момента е .

Angle изплаща дивидент на тримесечие. Той се разпределя в месеците .

Angle платеше дивиденда всяка година през последните 0 години.

За идните 12 месеца се очакват дивиденти в размер на 0 GBP. Това съответства на дивидентна доходност от 0 %.

Angle се отнася за сектор 'Здраве'.

За да получите последното дивидентно плащане от Angle на 7.07.2024 г. в размер на 0 GBP, трябваше да притежавате акцията в портфейла си преди Ex-деня на 7.07.2024 г..

Последното дивидентно плащане беше извършено на 7.07.2024 г..

През година 2023 Angle изплати 0 GBP под формата на дивиденти.

Дивидентите от Angle се изплащат в GBP.